Literature DB >> 22232246

ROCK cooperated with ET-1 to induce epithelial to mesenchymal transition through SLUG in human ovarian cancer cells.

Jin Peng1, Gong Zhang, Quansheng Wang, Jianguo Huang, Huan Ma, Yahua Zhong, Fuxiang Zhou, Conghua Xie, Ali Zhang.   

Abstract

The Rho-associated serine-threonine protein kinase (ROCK) is a downstream effector of Rho GTPases that is frequently activated in the epithelial to mesenchymal transition (EMT) of human ovarian cancer cells. On the other hand, endothelin-1 (ET-1) and its receptor endothelin A receptor (ET(A)R) are overexpressed in primary and metastatic ovarian carcinoma, which suggests that ET-1 promotes tumor dissemination. Hence, two human ovarian carcinoma cell lines, SK-OV-3 and CaOV3, were chosen to study the effects of ET-1/ET(A)R and ROCK in promoting EMT of ovarian cancer cells. We found that ET-1 exposure induced EMT of SK-OV-3 and CaOV3 by monitoring cells morphology, enhanced fibronectin, and reduced E-cadherin protein. At the same time, ET-1/ET(A)R enhanced the level of transcription of SLUG a transcriptional repressor of E-cadherin. More importantly, a constitutively active mutant of ROCK enhanced the transcription of SLUG by stimulating SLUG promoter activity. Furthermore, ROCK inhibitor Y27632 reversed the increase in fibronectin induced by ET-1/ET(A)R. Our data suggest that ROCK cooperated with ET-1/ET(A)R to promote EMT of human ovarian carcinoma cells through upregulation of SLUG mRNA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22232246     DOI: 10.1271/bbb.110411

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  11 in total

1.  Rho activation is apically restricted by Arhgap1 in neural crest cells and drives epithelial-to-mesenchymal transition.

Authors:  Matthew R Clay; Mary C Halloran
Journal:  Development       Date:  2013-06-26       Impact factor: 6.868

Review 2.  Endothelin 1 in cancer: biological implications and therapeutic opportunities.

Authors:  Laura Rosanò; Francesca Spinella; Anna Bagnato
Journal:  Nat Rev Cancer       Date:  2013-07-25       Impact factor: 60.716

3.  Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.

Authors:  Claudia Mera; Iván Godoy; Renato Ramírez; Jackeline Moya; María Paz Ocaranza; Jorge E Jalil
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-10-21

Review 4.  Novel Insights into the Roles of Rho Kinase in Cancer.

Authors:  Lei Wei; Michelle Surma; Stephanie Shi; Nathan Lambert-Cheatham; Jianjian Shi
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-01-02       Impact factor: 4.291

5.  Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3β/Slug Signaling Pathway.

Authors:  Jingjing Lu; Ying Xu; Xuan Wei; Zhe Zhao; Jing Xue; Peishu Liu
Journal:  Biomed Res Int       Date:  2016-12-20       Impact factor: 3.411

6.  Analysis of epithelial-mesenchymal transition markers in psoriatic epidermal keratinocytes.

Authors:  Xiao-Yong Man; Xi-Bei Chen; Wei Li; Lilla Landeck; Ting-Ting Dou; Jia-Qi Chen; Jiong Zhou; Sui-Qing Cai; Min Zheng
Journal:  Open Biol       Date:  2015-08       Impact factor: 6.411

7.  ROCK inhibition activates MCF-7 cells.

Authors:  Seungwon Yang; Hyun-Man Kim
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

8.  Endothelin-1 Drives Epithelial-Mesenchymal Transition in Hypertensive Nephroangiosclerosis.

Authors:  Teresa M Seccia; Brasilina Caroccia; Francesca Gioco; Maria Piazza; Valentina Buccella; Diego Guidolin; Eugenia Guerzoni; Barbara Montini; Lucia Petrelli; Elisa Pagnin; Verdiana Ravarotto; Anna S Belloni; Lorenzo A Calò; Gian Paolo Rossi
Journal:  J Am Heart Assoc       Date:  2016-07-21       Impact factor: 5.501

9.  The role of the endothelin axis in promoting epithelial to mesenchymal transition and lymph node metastasis in prostate adenocarcinoma.

Authors:  Sophia Papanikolaou; Vasiliki Bravou; Helen Papadaki; Kostis Gyftopoulos
Journal:  Urol Ann       Date:  2017 Oct-Dec

10.  ROCK inhibitor enhances the growth and migration of BRAF-mutant skin melanoma cells.

Authors:  Fei Chang; Yunpeng Zhang; Jun Mi; Qian Zhou; Fuxiang Bai; Xin Xu; David E Fisher; Qinfeng Sun; Xunwei Wu
Journal:  Cancer Sci       Date:  2018-09-23       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.